Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L3RY
|
|||
| Former ID |
DNC007404
|
|||
| Drug Name |
3-methoxy-N-(4-methylthiazol-2-yl)benzamide
|
|||
| Synonyms |
CHEMBL211740; 477516-34-0; 3-methoxy-N-(4-methyl-1,3-thiazol-2-yl)benzamide; SMR000155061; AC1MAGB1; 3-methoxy-N-(4-methylthiazol-2-yl)benzamide; Oprea1_281072; Oprea1_273858; MLS000569675; CTK4J0236; cid_2679292; DTXSID80369021; MolPort-000-631-036; CHEBI:114888; HMS2341M09; ZINC3562014; BDBM50186332; AKOS001313290; MCULE-7375167923; KB-288021; BENZAMIDE, 3-METHOXY-N-(4-METHYL-2-THIAZOLYL)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H12N2O2S
|
|||
| Canonical SMILES |
CC1=CSC(=N1)NC(=O)C2=CC(=CC=C2)OC
|
|||
| InChI |
1S/C12H12N2O2S/c1-8-7-17-12(13-8)14-11(15)9-4-3-5-10(6-9)16-2/h3-7H,1-2H3,(H,13,14,15)
|
|||
| InChIKey |
PAGPVSQZNPBQLP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 477516-34-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:114888
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3371-5. | |||
| REF 2 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.